Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 281, Issue 7, Pages 4292-4299Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M511018200
Keywords
-
Categories
Funding
- NIA NIH HHS [T32 AG00255, AG11542, AG008012] Funding Source: Medline
Ask authors/readers for more resources
Passive immunization of murine models of Alzheimer disease amyloidosis reduces amyloid-beta peptide (A beta) levels and improves cognitive function. To specifically address the role of A beta oligomers in learning and memory, we generated a novel monoclonal antibody, NAB61, that preferentially recognizes a conformational epitope present in dimeric, small oligomeric, and higher order A beta structures but not full-length amyloid-beta precursor protein or C-terminal amyloid-beta precursor protein fragments. NAB61 also recognized a subset of brain A beta deposits, preferentially mature senile plaques, and amyloid angiopathy. Using NAB61 as immunotherapy, we showed that aged Tg2576 transgenic mice treated with NAB61 displayed significant improvements in spatial learning and memory relative to control mice. These data implicated A beta oligomers as a pathologic substrate for cognitive decline in Alzheimer disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available